Kamyar Kalantar-Zadeh
The International Federation of Kidney Foundation – World Kidney Alliance (IFKF-WKA), Division of Nephrology and Hypertension and Kidney Transplantation, University of California Irvine, Orange, California, USA
https://orcid.org/0000-0002-8666-0725
Philip Li
Department of Medicine and Therapeutics, Carol & Richard Yu PD Research Centre, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong, China
https://orcid.org/0000-0001-9879-8388
Ekamol Tantisattamo
Division of Nephrology, Hypertension and Kidney Transplantation, Department of Medicine, University of California Irvine School of Medicine, Orange, California, USA
https://orcid.org/0000-0003-0883-6892
Latha Kumaraswami
Tanker Foundation, Chennai, India
Vassilios Liakopoulos
Division of Nephrology and Hypertension, 1st Department of Internal Medicine, AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
https://orcid.org/0000-0002-7564-2724
Siu-Fai Lui
Hong Kong Kidney Foundation and the International Federation of Kidney Foundations – World Kidney Alliance, The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China
https://orcid.org/0000-0003-0800-8982
Ifeoma Ulasi
Renal Unit, Department of Medicine, College of Medicine, University of Nigeria, Ituku-Ozalla, Enugu, Nigeria
https://orcid.org/0000-0001-7783-3025
Sharon Andreoli
James Whitcomb Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, Indiana, USA
Alessandro Balducci
Italian Kidney Foundation, Rome, Italy
Sophie Dupuis
World Kidney Day Office, Brussels, Belgium
Tess Harris
Polycystic Kidney Disease Charity, London, UK
https://orcid.org/0000-0003-3659-7438
Anne Hradsky
World Kidney Day Office, Brussels, Belgium
Richard Knight
American Association of Kidney Patients, Tampa, Florida, USA
Sajay Kumar
Tanker Foundation, Chennai, India
Maggie Ng
Hong Kong Kidney Foundation, Hong Kong, China
Alice Poidevin
World Kidney Day Office, Brussels, Belgium
Gamal Saadi
Nephrology Unit, Department of Internal Medicine, Faculty of Medicine, Cairo University, Giza, Egypt
https://orcid.org/0000-0002-6280-1685
Allison Tong
Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia
https://orcid.org/0000-0001-8973-9538
Abstract
Living with chronic kidney disease (CKD) is associated with hardships for patients and their care-partners. Empowering patients and their care-partners, including family members or friends involved in their care, may help minimize the burden and consequences of CKD related symptoms to enable life participation. There is a need to broaden the focus on living well with kidney disease and re-engagement in life, including an emphasis on patients being in control. The World Kidney Day (WKD) Joint Steering Committee has declared 2021 the year of “Living Well with Kidney Disease” in an effort to increase education and awareness on the important goal of patient empowerment and life participation. This calls for the development and implementation of validated patient-reported outcome measures to assess and address areas of life participation in routine care. It could be supported by regulatory agencies as a metric for quality care or to support labelling claims for medicines and devices. Funding agencies could establish targeted calls for research that address the priorities of patients. Patients with kidney disease and their care-partners should feel supported to live well through concerted efforts by kidney care communities including during pandemics. In the overall wellness program for kidney disease patients, the need for prevention should be reiterated. Early detection with a prolonged course of wellness despite kidney disease, after effective secondary and tertiary prevention programs, should be promoted. WKD 2021 continues to call for increased awareness of the importance of preventive measures throughout populations, professionals, and policy makers, applicable to both developed and developing countries.